| Literature DB >> 17332776 |
A Lamberti1, O Longo, M Marra, P Tagliaferri, E Bismuto, A Fiengo, C Viscomi, A Budillon, U R Rapp, E Wang, S Venuta, A Abbruzzese, P Arcari, M Caraglia.
Abstract
Interferon alpha (IFNalpha) induces both apoptosis and a counteracting epidermal growth factor Erk-dependent survival response in cancer cells. In this report, IFNalpha increased eukaryotic elongation factor 1A (eEF-1A) protein expression by inhibition of eEF-1A degradation via a proteasome-dependent pathway. The reduction of the expression level of eEF-1A by RNA interference enhanced the apoptosis induced by IFNalpha on the same cells. Moreover, IFNalpha induced the phosphorylation of both serine and threonine in eEF-1A. These effects were paralleled by an increased co-immunoprecipitation and colocalization of eEF-1A with C-Raf. The suppression of C-Raf kinase activity with the inhibitor BAY 43-9006 completely antagonized the increase of both eEF-1A phosphorylation and expression and of C-Raf/eEF-1A colocalization induced by IFNalpha and enhanced apoptosis and eEF-1A ubiquitination. Cell transfection with the mutated K48R ubiquitin increased EF-1A expression and desensitized tumor cells to the modulating effects of IFNalpha. The dynamic simulation of 3Dstructure of eEF-1A identified putative serine and threonine phosphorylation sites. In conclusion, the interaction between eEF-1A and C-Raf increases eEF-1A stability and induces a survival activity.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17332776 DOI: 10.1038/sj.cdd.4402102
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 15.828